CTOs on the Move

ProMetic

www.prometic.com

 
ProMetic Life Sciences Inc. (www.prometic.com) is a long established biopharmaceutical company with globally recognized expertise in bioseparation, plasma-derived therapeutics and small-molecule drug development. ProMetic offers its state of the art technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop best-in-class therapeutics and orphan drugs. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the field of ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.prometic.com
  • 440 Boul. Armand-Frappier Suite 300
    Laval, QC CAN H7V 4B4
  • Phone: 450.781.0115

Executives

Name Title Contact Details

Funding

ProMetic raised $30M on 03/01/2016

Similar Companies

Gala Design Inc

Gala Design Inc is a Middleton, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ST CATHRINE REGINAL HOSP

ST CATHRINE REGINAL HOSP is a Charlestown, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cebert Pharmaceuticals

Cebert Pharmaceuticals is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ADV-Care Pharmacy Inc

ADV-Care Pharmacy Inc is a Markham, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Phathom Pharmaceuticals

Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.